clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
NHS BRCA Testing for Those with Jewish Ancestry Huge Success
News & Features
Wearable Devices Can Predict Inflammatory Bowel Disease Flare-Ups
News & Features
Xenon Gas Inhalation Shows Promise for Alzheimer’s Disease
News & Features
Researchers Identify Immune Cells That Worsen Severe Asthma
News & Features
Breast Cancer Drug Shows Promise in Treating Blood Cancers
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Inside Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
MammaPrint
Molecular Dx
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
February 20, 2020
0
Related Content
NHS BRCA Testing for Those with Jewish Ancestry Huge Success
Breast Cancer Drug Shows Promise in Treating Blood Cancers
Boston-Based MedTherapy Announces New Tools for CAR-T Manufacturing
Lilly Pays up to $2.5B for Selective PI3Kα Inhibitor
Inside Precision Medicine
![One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/585.jpeg "Agendia Reports Positive Results in IMPACt Trial for Breast Cancer")
